Week 4: Signal Transduction III: TKIs in Colon and CLL Flashcards
What can cause over expression?
DNA amplification, increased transcription, decreased degradation of mRNA or protein
What usually causes constitutive activity?
Mutation in the gene
What is the chemotherapy for colon cancer in metastatic setting? Does it cure anyone?
5-FU with either irinotecan or oxaliplatin; doesn’t clear unless it’s in the adjuvant setting, only extends life by 2 years in metastatic setting
What gene is the driver of proliferation and survival in colon cancer?
EGFR
What genes are constitutively active in the EGFR pathway?
Ras and Raf
What is needed for the the blocking of EGFR to be successful?
Tumors that express wild-type ras and raf
What is MOA of panitumumab?
blocks EGFR
What can panitumumab be used to treat?
colon cancer, squamos cancers of head and neck, squamos cancers of cervix and penis
What is the most common form of leukemia?
Chronic lymphocytic leukemia
What are the two phenotypes of CLL?
node-predominant and leukemia (circuilating)
What proteins are consider in the prognosis of CLL patients?
Ki67 and Bax/BCL-2 ratio
What does CLL usually present with?
autoimmune phenomena: immune thrombocytopenic purpura, AIHA, autoimmune agranulocytosis. hypogammaglobulinemia and virulent infections
What is constitutively expressed in CLL?
non-mutated Bruton’s tyrosine kinase
What are the treatments for CLL?
Rituximab, chlorambucil, BTK inhibitors (Ibrutinib), Idelalisib, venetoclax (Bcl-2 modulator)
What is the MOA of ibrutinib?
BTK inhibitor; covalent modifier of ATP binding site on BTK